search
Back to results

A Mindful Community for People With ALS and Their Primary Caregivers

Primary Purpose

Amyotrophic Lateral Sclerosis, Caregiver Burden

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Mindfulness
Mindful Learning
Sponsored by
Harvard University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Amyotrophic Lateral Sclerosis focused on measuring Mindfulness, Quality of Life

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

For the ALS patients

  • a definite, probable, laboratory-supported, or possible ALS by revised El-Escorial criteria
  • they must have the physical ability, with or without adaptive devices, to use a smartphone, a tablet, or a computer
  • have access to the Internet.

For the caregivers

  • be the person who resides with the ALS patient and is the major provider of unpaid care and assistance (typically, the spouse or another close relative)
  • s/he must be able to use the application
  • have access to the Internet.

Exclusion criteria

- Using shared devices. Patients and caregivers should have their own devices.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Mindfulness

    Mindful Learning

    Arm Description

    Three-week online mindfulness course followed by one-month social community online interaction.

    Three-week online mindful learning course followed by one-month social community online interaction

    Outcomes

    Primary Outcome Measures

    ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF) - For PALS (Persons with ALS)
    The ALSSQOL-SF is a 20 item quality of life instrument for patients. It has a 0-10 rating scale with higher scores denoting higher QOL.
    World Health Organization Quality of Life (Brief) WHO-QoL BREF - For Caregivers of PALS
    The WHO-QoL BREF is a 26 item quality of life scale covering four domains of QOL. Each item is scored from 1-5 with higher response employing a higher quality of life. Items are scored from 1-5

    Secondary Outcome Measures

    Hospital Anxiety and Depression Scale (HADS)
    The HADS measures anxiety and depression in a general medical population of patients. It has seven items each for depression and anxiety sub scales. Scoring ranges from 0 to 3, with 3 denoting the highest anxiety or depression level. A total sub scale score of over 8 out of 21 denotes considerable symptoms of either.
    Functional Status
    Self-Administered Functional Rating Scale Revised
    Zarit Burden Interview
    The ZBI consists of 22 items rated on a 5-point Likert scale that ranges from 0 (never) to 4 (nearly always) with the sum of scores ranging between 0-88. Higher scores indicate greater burden. A score of 17 or more has been considered high burden.
    ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF)
    The ALSSQOL-SF is a 20 item quality of life instrument for patients. It has a 0-10 rating scale with higher scores denoting higher QOL.
    World Health Organization Quality of Life (Brief) WHO-QoL BREF
    The WHO-QoL BREF is a 16 item quality of life scale covering four domains of QOL. Each item is scored from 1-5 with higher response employing a higher quality of life.

    Full Information

    First Posted
    September 12, 2022
    Last Updated
    September 20, 2023
    Sponsor
    Harvard University
    Collaborators
    Catholic University of the Sacred Heart
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05595850
    Brief Title
    A Mindful Community for People With ALS and Their Primary Caregivers
    Official Title
    A Mindful Community for People With ALS and Their Primary Caregivers
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 31, 2023 (Anticipated)
    Primary Completion Date
    January 1, 2024 (Anticipated)
    Study Completion Date
    March 31, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Harvard University
    Collaborators
    Catholic University of the Sacred Heart

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The psychological impact of ALS on patients and caregivers is high, significantly affecting their quality of life (QOL). Despite this impact, there is not much research about psychological interventions that could reduce psychological distress and improve QOL. The efficacy of mindfulness-based treatments for the improvement of QOL was previously demonstrated by the investigator's group. Despite preliminary positive results, treatment efficacy tends to weaken over time. The investigators believe that a robust solution to maintain efficacy is to maximize the utilization of technology and emerging social platforms, establishing a "mindful community" to promote and continuously reinforce mindfulness. This project's primary aims are 1) to develop a "mindful" online community of people with ALS and their caregivers, and 2) to test its efficacy in QOL improvement. This two-part intervention consists of 1) optimizing the investigator's prior e-learning platform with a three-week program including cognitive exercises, videos and lectures to increase participants' mindfulness; and 2) involving participants in a "mindfulness community" within a social sharing forum. Assessments will be performed before and immediately post-treatment as well as 3- and 6-months post-program comparing subjects undergoing the intervention to a control group.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Amyotrophic Lateral Sclerosis, Caregiver Burden
    Keywords
    Mindfulness, Quality of Life

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    300 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Mindfulness
    Arm Type
    Experimental
    Arm Description
    Three-week online mindfulness course followed by one-month social community online interaction.
    Arm Title
    Mindful Learning
    Arm Type
    Active Comparator
    Arm Description
    Three-week online mindful learning course followed by one-month social community online interaction
    Intervention Type
    Behavioral
    Intervention Name(s)
    Mindfulness
    Intervention Description
    Online non-meditation mindfulness program
    Intervention Type
    Behavioral
    Intervention Name(s)
    Mindful Learning
    Intervention Description
    Online learning program
    Primary Outcome Measure Information:
    Title
    ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF) - For PALS (Persons with ALS)
    Description
    The ALSSQOL-SF is a 20 item quality of life instrument for patients. It has a 0-10 rating scale with higher scores denoting higher QOL.
    Time Frame
    3 months
    Title
    World Health Organization Quality of Life (Brief) WHO-QoL BREF - For Caregivers of PALS
    Description
    The WHO-QoL BREF is a 26 item quality of life scale covering four domains of QOL. Each item is scored from 1-5 with higher response employing a higher quality of life. Items are scored from 1-5
    Time Frame
    3 months
    Secondary Outcome Measure Information:
    Title
    Hospital Anxiety and Depression Scale (HADS)
    Description
    The HADS measures anxiety and depression in a general medical population of patients. It has seven items each for depression and anxiety sub scales. Scoring ranges from 0 to 3, with 3 denoting the highest anxiety or depression level. A total sub scale score of over 8 out of 21 denotes considerable symptoms of either.
    Time Frame
    3 weeks, 3 months, 6 months after joining
    Title
    Functional Status
    Description
    Self-Administered Functional Rating Scale Revised
    Time Frame
    3 weeks, 3 months, 6 months after joining
    Title
    Zarit Burden Interview
    Description
    The ZBI consists of 22 items rated on a 5-point Likert scale that ranges from 0 (never) to 4 (nearly always) with the sum of scores ranging between 0-88. Higher scores indicate greater burden. A score of 17 or more has been considered high burden.
    Time Frame
    3 weeks, 3 months, 6 months after joining
    Title
    ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF)
    Description
    The ALSSQOL-SF is a 20 item quality of life instrument for patients. It has a 0-10 rating scale with higher scores denoting higher QOL.
    Time Frame
    3 weeks, 3 months, 6 months after joining
    Title
    World Health Organization Quality of Life (Brief) WHO-QoL BREF
    Description
    The WHO-QoL BREF is a 16 item quality of life scale covering four domains of QOL. Each item is scored from 1-5 with higher response employing a higher quality of life.
    Time Frame
    3 weeks, 3 months, 6 months after joining

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: For the ALS patients a definite, probable, laboratory-supported, or possible ALS by revised El-Escorial criteria they must have the physical ability, with or without adaptive devices, to use a smartphone, a tablet, or a computer have access to the Internet. For the caregivers be the person who resides with the ALS patient and is the major provider of unpaid care and assistance (typically, the spouse or another close relative) s/he must be able to use the application have access to the Internet. Exclusion criteria - Using shared devices. Patients and caregivers should have their own devices.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Deborah R Phillips, PhD
    Phone
    9739027938
    Email
    dphillips@fas.harvard.edu
    First Name & Middle Initial & Last Name or Official Title & Degree
    Francesco Pagnini, PhD
    Email
    francesco.pagnini@unicatt.it
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ellen Langer, PhD
    Organizational Affiliation
    Harvard U
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    A Mindful Community for People With ALS and Their Primary Caregivers

    We'll reach out to this number within 24 hrs